ANIK 8-K 2026-11-06

Anika Therapeutics, Inc. (ANIK) 8-K dated 2026-11-06 — accession 0001171843-26-007211.

Anika Therapeutics, Inc. (ANIK) is a drug manufacturers - specialty & generic company listed on US.

ANIK sales +10% YoY

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ANIK revenue for 2025-12-31 was $112.8M. Net income was -$10.9M. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. ANIK currently screens at market cap $161.3M.

Not investment advice. The ANIK SEC hub lists recent forms. The stock page is the research view.